Results 41 to 50 of about 8,541 (196)

Does Unilateral DIPNECH Provide Clues to Pathogenesis? [PDF]

open access: yes, 1968
Digitalitzat per ...
Miller, York E.
core   +1 more source

Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non-mTOR-mediated etiologies. [PDF]

open access: yes, 2018
The present study was designed to examine the potential cellular antiseizure mechanisms of everolimus, a mechanistic target of rapamycin (mTOR) pathway blocker, in pediatric epilepsy cases. Cortical tissue samples obtained from pediatric patients (n 
Barry, Joshua   +8 more
core   +2 more sources

Tuberous sclerosis complex presenting as pulmonary lymphangioleiomyomatosis - a clinicoradiological diagnosis

open access: yesThe Pan African Medical Journal, 2015
Tuberous sclerosis complex (TSC) manifests predominantly as a neurocutaneous disorder. Lymphangioleiomyomatosis (LAM) is a rare pulmonary manifestation of TSC.
Kamini Gupta   +3 more
doaj   +1 more source

Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care. [PDF]

open access: yes, 2019
Tuberous sclerosis complex (TSC) is an autosomal dominant multisystem genetic disorder characterized by benign tumors in multiple organs, including the skin, brain, kidneys, and lungs and occasional malignant tumors.
Adriaensen   +32 more
core   +5 more sources

Recent advances in the management of lymphangioleiomyomatosis [version 1; referees: 4 approved]

open access: yesF1000Research, 2018
Lymphangioleiomyomatosis is a rare disorder that predominantly affects women and is characterized by progressive cystic changes in the lung, leading to gradually worsening shortness of breath and lung function impairment.
Kai-Feng Xu, Xinlun Tian, Jay H Ryu
doaj   +1 more source

Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response

open access: yesThe Journal of Pathology: Clinical Research, 2020
Lymphangioleiomyomatosis (LAM) is a rare multisystem disease with a variable clinical course. The lungs are infiltrated by nodules of LAM cells, stromal cells and inflammatory cells, causing lung cysts and respiratory failure. We used immunohistochemical
Suzanne Miller   +5 more
doaj   +1 more source

Lymphangioleiomyomatosis (LAM) [PDF]

open access: yesBreathe, 2017
LAM is characterised by lung cysts (air-filled sacs which gradually destroy the lung), changes to the lymphatic system and tumours in the kidneys.
openaire   +2 more sources

Meningiomas in Lymphangioleiomyomatosis [PDF]

open access: yesJAMA, 2001
Lymphangioleiomyomatosis (LAM), a cystic lung disease associated with progressive respiratory failure, is found predominantly in women of childbearing age and therefore has been treated with progesterone and other hormonal agents. However, meningiomas have progesterone receptors, and progesterone is believed to be a mitogen for meningioma cells in ...
Angelo M. Taveira-DaSilva   +3 more
openaire   +3 more sources

Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide [PDF]

open access: yes, 2017
Tuberous sclerosis complex (TSC) is a genetic disorder characterised by highly variable comorbid dysfunction and subsequent morbidity. The mTOR inhibitor everolimus is indicated for the treatment of adult TSC patients with renal angiomyolipomas (AMLs ...
Davies, Mark   +2 more
core   +2 more sources

Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex. [PDF]

open access: yesPLoS ONE, 2016
Tuberous Sclerosis Complex (TSC) is an autosomal dominant tumor suppressor gene syndrome in which patients develop several types of tumors, including facial angiofibroma, subungual fibroma, Shagreen patch, angiomyolipomas, and lymphangioleiomyomatosis ...
Yanan Guo   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy